Literature DB >> 22234308

POTE protein, a cancer-testis antigen, is highly expressed in spermatids in human testis and is associated with apoptotic cells.

Tapan K Bera1, Dawn A Walker, Richard J Sherins, Ira Pastan.   

Abstract

The POTE gene family encodes very closely related proteins that are highly expressed in testis and in many cancers. Recent studies indicate that the POTE proteins have a pro-apoptotic function. To examine if POTE is associated with cells that are undergoing apoptosis in testis, we determined the cellular location of POTE and of Cleaved Caspase-3 in testicular tissues from 26 azoospermic men. We found intense expression of POTE in round spermatids that are undergoing apoptosis, which are positive for Cleaved Caspase-3. This study suggests POTE may have a role in apoptosis in the human testis. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22234308      PMCID: PMC3278037          DOI: 10.1016/j.bbrc.2011.12.125

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  The relevance of spontaneous- and chemically-induced alterations in testicular germ cell apoptosis to toxicology.

Authors:  J H Richburg
Journal:  Toxicol Lett       Date:  2000-03-15       Impact factor: 4.372

Review 2.  Germ cell suicide: new insights into apoptosis during spermatogenesis.

Authors:  C G Print; K L Loveland
Journal:  Bioessays       Date:  2000-05       Impact factor: 4.345

3.  Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3.

Authors:  Allen M Gown; Mark C Willingham
Journal:  J Histochem Cytochem       Date:  2002-04       Impact factor: 2.479

4.  POTE paralogs are induced and differentially expressed in many cancers.

Authors:  Tapan K Bera; Ashley Saint Fleur; Yoomi Lee; Andre Kydd; Yoonsoo Hahn; Nicholas C Popescu; Drazen B Zimonjic; Byungkook Lee; Ira Pastan
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

5.  Evolution and expression of chimeric POTE-actin genes in the human genome.

Authors:  Yoomi Lee; Tomoko Ise; Duc Ha; Ashley Saint Fleur; Yoonsoo Hahn; Xiu-Fen Liu; Satoshi Nagata; Byungkook Lee; Tapan K Bera; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

6.  A primate-specific POTE-actin fusion protein plays a role in apoptosis.

Authors:  Xiu Fen Liu; Tapan K Bera; Lisa J Liu; Ira Pastan
Journal:  Apoptosis       Date:  2009-10       Impact factor: 4.677

Review 7.  Hormonal and genetic control of germ cell apoptosis in the testis.

Authors:  A P Sinha Hikim; R S Swerdloff
Journal:  Rev Reprod       Date:  1999-01

8.  Fas and Fas ligand expression in fetal and adult human testis with normal or deranged spermatogenesis.

Authors:  S Francavilla; P D'Abrizio; N Rucci; G Silvano; G Properzi; E Straface; G Cordeschi; S Necozione; L Gnessi; M Arizzi; S Ulisse
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

9.  Expression of Bcl-2 family proteins and spontaneous apoptosis in normal human testis.

Authors:  N B Oldereid; P D Angelis; R Wiger; O P Clausen
Journal:  Mol Hum Reprod       Date:  2001-05       Impact factor: 4.025

10.  Five POTE paralogs and their splice variants are expressed in human prostate and encode proteins of different lengths.

Authors:  Tapan K Bera; Nancy Huynh; Hiroshi Maeda; Bangalore K Sathyanarayana; Byungkook Lee; Ira Pastan
Journal:  Gene       Date:  2004-08-04       Impact factor: 3.688

View more
  8 in total

1.  The C-terminal common to group 3 POTES (CtG3P): a newly discovered nucleolar marker associated with malignant progression and metastasis.

Authors:  Samantha M Redfield; Jinghe Mao; He Zhu; Zhi He; Xu Zhang; Steven A Bigler; Xinchun Zhou
Journal:  Am J Cancer Res       Date:  2013-06-20       Impact factor: 6.166

2.  Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small-cell lung cancer.

Authors:  Qi Wang; Xuefei Li; Shengxiang Ren; Ningning Cheng; Mingchuan Zhao; Yishi Zhang; Jiayu Li; Weijing Cai; Chao Zhao; Wa Cao; Caicun Zhou
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

3.  Androgen-induced lncRNA POTEF-AS1 regulates apoptosis-related pathway to facilitate cell survival in prostate cancer cells.

Authors:  Aya Misawa; Ken-Ichi Takayama; Tetsuya Fujimura; Yukio Homma; Yutaka Suzuki; Satoshi Inoue
Journal:  Cancer Sci       Date:  2017-03       Impact factor: 6.716

4.  Down-regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients.

Authors:  Ling Wang; Mengqing Li; Yuting Zhan; Xiaojiao Ban; Tingting Zeng; Yinghui Zhu; Jingping Yun; Xin-Yuan Guan; Yan Li
Journal:  Mol Carcinog       Date:  2018-04-06       Impact factor: 4.784

5.  Population-specific, recent positive directional selection suggests adaptation of human male reproductive genes to different environmental conditions.

Authors:  Helmut Schaschl; Bernard Wallner
Journal:  BMC Evol Biol       Date:  2020-02-13       Impact factor: 3.260

6.  BESFA: bioinformatics based evolutionary, structural & functional analysis of prostrate, Placenta, Ovary, Testis, and Embryo (POTE) paralogs.

Authors:  Sahar Qazi; Bimal Prasad Jit; Abhishek Das; Muthukumarasamy Karthikeyan; Amit Saxena; M D Ray; Angel Rajan Singh; Khalid Raza; B Jayaram; Ashok Sharma
Journal:  Heliyon       Date:  2022-09-05

7.  Expression of the POTE gene family in human ovarian cancer.

Authors:  Carter J Barger; Wa Zhang; Ashok Sharma; Linda Chee; Smitha R James; Christina N Kufel; Austin Miller; Jane Meza; Ronny Drapkin; Kunle Odunsi; David Klinkebiel; Adam R Karpf
Journal:  Sci Rep       Date:  2018-11-20       Impact factor: 4.379

8.  N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets.

Authors:  Guoqing Zhu; Feng Wang; Haojie Li; Xiao Zhang; Qi Wu; Ya Liu; Mingping Qian; Susu Guo; Yueyue Yang; Xiangfei Xue; Fenyong Sun; Yongxia Qiao; Qiuhui Pan
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.